Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma
Background Although bile duct resection (BDR) in addition to pancreaticoduodenectomy (PD) is considered a surgical approach in patients with middle-third cholangiocarcinoma (MCC), available prognostic information after BDR remains very limited. The aim of this study was to reappraise BDR from the vi...
Saved in:
Published in | Annals of surgical oncology Vol. 28; no. 4; pp. 1990 - 1999 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.04.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Although bile duct resection (BDR) in addition to pancreaticoduodenectomy (PD) is considered a surgical approach in patients with middle-third cholangiocarcinoma (MCC), available prognostic information after BDR remains very limited. The aim of this study was to reappraise BDR from the viewpoint of surgical oncology.
Methods
Patients who underwent BDR or PD for MCC between 2001 and 2010 at 32 Japanese hospitals were included. Clinicopathological factors were retrospectively compared according to surgical procedure to identify a subset cohort who benefited most from BDR.
Results
During the study, 92 patients underwent BDR (
n
= 38) or PD (
n
= 54). BDR was characterized by a shorter operation time, less blood loss, less frequent complications, and lower mortality, than PD. The incidence of positive surgical margins was 26.3% versus 5.6% (
P
= 0.007). The survival rate after BDR was significantly worse than that after PD: 38.8% versus 54.8% at 5 years (
P
= 0.035), and BDR was independently associated with deteriorated survival [hazard ratio (HR), 1.76;
P
= 0.023] by multivariable analysis. In the BDR group, tumor length < 15 mm (HR, 3.38;
P
= 0.017) and ductal margin length ≥ 10 mm (HR, 2.54;
P
= 0.018) were independent positive prognostic factors. Stratified by these two favorable factors, the 5-year survival rate was 63.0% in patients with 1/2 factors and 6.7% in those with 0 factors (
P
< 0.001).
Conclusion
In patients with MCC, BDR provided a better short-term and a worse long-term outcome than PD. However, patient selection using tumor length and ductal margin length may allow a favorable survival probability even after BDR. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1068-9265 1534-4681 |
DOI: | 10.1245/s10434-020-09157-3 |